Larimar Therapeutics, Inc.

( )
LRMR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.27%157.580.0%$684.42m
AMGNAmgen, Inc. -0.07%250.411.5%$604.04m
GILDGilead Sciences, Inc. 0.23%66.171.0%$438.81m
VRTXVertex Pharmaceuticals, Inc. 0.80%301.611.9%$418.03m
REGNRegeneron Pharmaceuticals, Inc. 0.58%640.002.6%$366.71m
ILMNIllumina, Inc. -0.01%213.013.3%$317.75m
SNSSSunesis Pharmaceuticals, Inc. 0.00%4.060.7%$283.81m
NVAXNovavax, Inc. 0.33%39.5075.7%$259.73m
BIIBBiogen, Inc. -0.64%216.181.8%$190.88m
BNTXBioNTech SE 0.15%152.270.0%$149.42m
GOVXGeoVax Labs, Inc. -2.21%2.210.0%$117.26m
BMRNBioMarin Pharmaceutical, Inc. 0.17%95.004.2%$100.51m
SAVACassava Sciences, Inc. 3.58%26.640.0%$98.48m
CRSPCRISPR Therapeutics AG 2.00%73.180.6%$93.90m
MRTXMirati Therapeutics, Inc. 0.97%81.001.6%$88.32m

Company Profile

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.